Sep 26, 2023
Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market
Shares of Vertex Pharmaceuticals Inc. VRTX, +0.46% inched
Shares of Vertex Pharmaceuticals Inc. VRTX, +0.46% inched 0.46% higher to $334.11 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.11% rising 0.11% to 4,298.86 and the Dow Jones Industrial Average DJIA, +0.13% rising 0.13% to 33,876.78.
This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals Inc. closed $20.35 below its 52-week high ($354.46), which the company reached on May 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. ABBV, +0.39% rose 0.39% to $138.18, Krystal Biotech Inc. KRYS, +0.72% rose 0.72% to $128.92, and Arcturus Therapeutics Holdings Inc. ARCT, -3.17% fell 3.17% to $27.49.
Trading volume (1.1 M) remained 145,038 below its 50-day average volume of 1.2 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
TreeHouse Foods is the only major publicly traded pure play on increasingly popular private-label food products. The stock is cheap—but it might not stay that way for long.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.